◀ Back to NOS1
IL2 — NOS1
Text-mined interactions from Literome
Heitmeier et al., J Biol Chem 1999
(Insulinoma) :
Prolonged STAT1 activation is associated with interferon-gamma priming for
interleukin-1 induced inducible
nitric-oxide synthase expression by islets of Langerhans
Jyothi et al., Scand J Immunol 2000
(Neoplasms, Experimental) :
Interleukin-2 induced
nitric oxide synthase and nuclear factor-kappaB activity in activated natural killer cells and the production of interferon-gamma
Erickson et al., Urology 2001
(Cystitis, Interstitial) :
Markers that changed after treatment were as follows : ( 1 )
nitric oxide synthase and cyclic guanosine monophosphate
increased with oral L-arginine ; ( 2 ) ECP decreased with subcutaneous heparin ; ( 3 ) prostaglandin E ( 2 ) and kallikrein decreased after bladder distention ; ( 4 ) neutrophil chemotactic activity decreased after dimethyl sulfoxide ; ( 5 )
IL-2 inhibitor decreased after oral nifedipine ; ( 6 ) IL-2, IL-6, and IL-8 decreased after bacille Calmette-Guérin ( BCG ) vaccine ; and ( 7 ) APF and heparin binding epidermal growth factor changed to or toward normal levels after bladder distention or sacral nerve stimulation
Miljkovic et al., Cell Mol Life Sci 2003
:
The
role of
interleukin-17 in inducible
nitric oxide synthase mediated nitric oxide production in endothelial cells
Cattaruzza et al., J Biol Chem 2003
:
Interleukin-10 induction of
nitric-oxide synthase expression
attenuates CD40 mediated
interleukin-12 synthesis in human endothelial cells
Miljkovic et al., Cytokine Growth Factor Rev 2004
(Inflammation...) :
Inducible
nitric oxide synthase activation by
interleukin-17
Qian et al., Vascul Pharmacol 2006
(Diabetes Mellitus, Experimental) :
IL-2 ( 1000 U/ml ) significantly
attenuated the decrease of SOD and
NOS activity caused by high glucose
Szabó et al., Eur J Pharmacol 1993
:
We investigated the
role of
interleukin-1 in the induction of a Ca ( 2+ ) -independent
nitric oxide ( NO ) synthase by bacterial endotoxin in vivo
Tetsuka et al., Proc Natl Acad Sci U S A 1994
:
Cross-talk between cyclooxygenase and nitric oxide pathways : prostaglandin E2 negatively modulates
induction of
nitric oxide synthase by
interleukin 1
Kanno et al., Hypertension 1993
:
Induction of
nitric oxide synthase gene by
interleukin in vascular smooth muscle cells
Karanth et al., Proc Natl Acad Sci U S A 1993
:
The data indicate that
IL-2 can
activate constitutive NOS leading to increased NO release, which activates CRF release
Leder et al., Eur Surg Res 1996
(Lung Neoplasms...) :
To elucidate whether inhibition of the
IL-2 induced
NOS could boost efficacy of IL-2 stimulated CTLs in vivo, we assessed lung metastases in mice injected with IL-2, the NOS inhibitor aminoguanidine ( AG ), their combination and the diluent
Heitmeier et al., J Biol Chem 1997
:
Interferon-gamma increases the sensitivity of islets of Langerhans for inducible
nitric-oxide synthase expression
induced by
interleukin 1
Williams et al., J Immunol 1998
:
TCR stimulated expression of functional Fas ligand was attenuated in a stereospecific manner by
NOS inhibitors, but these compounds did not
inhibit TCR stimulated
IL-2 secretion or CD69 surface expression